Congratulations to the winners of the FEBS Anniversary Prizes 2016!
FEBS Anniversary Prizes of the Gesellschaft für Biochemie und Molekularbiologie (GBM) are awarded for outstanding achievements in the field of Biochemistry and Molecular Biology or related sciences by the upcoming generation of senior scientists, with the awardees selected from researchers under 40 years of age invited to give a lecture at one of the symposia or workshops held during a FEBS Congress. The prize administration is managed by both FEBS and GBM, and up to two Anniversary Prizes of €2000 are awarded each year.
FEBS and GBM are pleased to announce that this year's recipients of the prize are Milena Bellin (Leiden, The Netherlands) and Sven Diederichs (Freiburg and Heidelberg, Germany). Following Congress cancellation, both Anniversary Prizewinners are kindly sending slide presentations for delegates to view on the Congress website from 5th September.
For more information on FEBS awards, click here.
Assistant Professor Milena Bellin is at the Department of Anatomy and Embryology, Leiden University Medical Center, Leiden, The Netherlands. Her research is focused on the use of human pluripotent stem cells (hPSCs) for cardiac differentiation and for studying and treating congenital arrhythmogenic cardiac diseases, with her current work encompassing drug-screening, gene targeting and development of 3D cardiac microtissues. She derived the first cardiac isogenic hPSC pairs for unravelling the molecular mechanisms underlying the type-2 long-QT syndrome and also generated a hPSC model to study Jervell and Lange-Nielsen syndrome. Her talk at the FEBS Congress was to cover ‘Isogenic human pluripotent stem cell pairs to study long-QT syndrome’ in a Symposium on ‘Cardiac regeneration: Programming human heart cells’.
Professor Sven Diederichs leads the Division of Cancer Research, Department of Thoracic Surgery, University of Freiburg, Germany and the Division of RNA Biology & Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. His work focuses on the functional and mechanistic characterization of long non-coding RNAs (lncRNAs) as well as their interacting proteins in cancer, using methods of molecular biology and biochemistry. Importantly, he discovered the lncRNA MALAT1 as one of the first lncRNAs linked to cancer and proved its active role as epigenetic regulator in the development of lung cancer metastases. As a Symposium Chair for the FEBS Congress, he had organized the session on ‘RNA biology, biogenesis and processing’, where he was intending to speak on ‘Long non-coding RNAs – Messages from the dark matter of the lung cancer genome’.